Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 15451-15500 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT03924895
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Participants Who Are Cisplatin-ineligible or Decline Cisplatin With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)
PHASE3Active, not recruiting
595 participants
Started: Jul 24, 2019 · Completed: Dec 15, 2027
1 condition3 sponsors242 locations
NCT03779490
Transcatheter Repair of Tricuspid Regurgitation With Edwards Cardioband TR System Post Market Study (TriBAND)
N/AActive, not recruiting
150 participants
Started: Jul 24, 2019 · Completed: Dec 31, 2027
2 conditions1 sponsor14 locations
NCT06400225
Testing BVD-523FB (Ulixertinib) as Potentially Targeted Treatment in Cancers With Genetic Changes (MATCH - Subprotocol Z1L)
PHASE2Active, not recruiting
35 participants
Started: Jul 24, 2019 · Completed: Dec 31, 2026
5 conditions1 sponsor1 location
NCT03965676
Evolution of Tophus and Erosions of Hands and Feet at DECT
NAActive, not recruiting
50 participants
Started: Jul 24, 2019 · Completed: Oct 11, 2025
1 condition2 sponsors2 locations
NCT04143607
ASK120067 Versus Gefitinib as First-line Treatment for EGFRm Locally Advanced or Metastatic NSCLC
PHASE3Active, not recruiting
337 participants
Started: Jul 23, 2019 · Completed: Sep 30, 2026
1 condition1 sponsor3 locations
NCT03978650
Risk Factors for Falls and Fall-related Injuries Associated With Mild Neurocognitive Disorders
N/AActive, not recruiting
12,000 participants
Started: Jul 23, 2019 · Completed: Jan 1, 2026
3 conditions1 sponsor1 location
NCT03977194
Atezolizumab in Elderly Patients With Advanced Non-Small-Cell Lung Cancer and Receiving Carboplatin Paclitaxel Chemotherapy
PHASE3Active, not recruiting
500 participants
Started: Jul 23, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor68 locations
NCT06276036
Autoimmune Cytopenias as a Sign of Primary Immunodeficiency.
NAActive, not recruiting
53 participants
Started: Jul 23, 2019 · Completed: Jun 1, 2025
1 condition1 sponsor6 locations
NCT04024540
Isocaloric Dietary Restriction vs. Bariatric Surgery for Obesity Treatment
NAActive, not recruiting
72 participants
Started: Jul 23, 2019 · Completed: Dec 1, 2024
1 condition1 sponsor1 location
NCT03945552
Pediatric Parenting Support in Flint
NAActive, not recruiting
486 participants
Started: Jul 23, 2019 · Completed: Feb 28, 2026
2 conditions5 sponsors2 locations
NCT03654105
Screening and Multiple Intervention on Lung Epidemics
PHASE2Active, not recruiting
2,000 participants
Started: Jul 23, 2019 · Completed: Dec 31, 2026
5 conditions2 sponsors1 location
NCT03916627
Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients
PHASE2Active, not recruiting
65 participants
Started: Jul 23, 2019 · Completed: May 14, 2030
3 conditions1 sponsor1 location
NCT04017273
Older Emergency Department Users and Hospitalization After an Index Visit: Results of ER2 Database
N/AActive, not recruiting
10,971 participants
Started: Jul 23, 2019 · Completed: Dec 1, 2025
2 conditions1 sponsor1 location
NCT03628768
Risk Factors for Falls and Neurocognitive Disorders CLSA
N/AActive, not recruiting
12,000 participants
Started: Jul 23, 2019 · Completed: Feb 28, 2026
2 conditions1 sponsor1 location
NCT03962972
Association of Centre of Excellence Self-Administered Questionnaire (CESAM) Score and Frailty Levels
N/AActive, not recruiting
1,741 participants
Started: Jul 23, 2019 · Completed: Jan 1, 2025
3 conditions1 sponsor1 location
NCT04022551
Emergency Room Evaluation and Recommendations for Older Users of Emergency Departments
N/AActive, not recruiting
4,724 participants
Started: Jul 23, 2019 · Completed: Sep 1, 2024
3 conditions1 sponsor1 location
NCT04046445
Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer
PHASE1Active, not recruiting
96 participants
Started: Jul 22, 2019 · Completed: Aug 31, 2025
6 conditions2 sponsors12 locations
NCT02910414
TARGET BP I Clinical Trial
PHASE3Active, not recruiting
300 participants
Started: Jul 22, 2019 · Completed: May 31, 2026
1 condition1 sponsor5 locations
NCT04206540
Effect of Stimulation on the Vagus Nerve
NAActive, not recruiting
30 participants
Started: Jul 22, 2019 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT03844750
Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases
PHASE2Active, not recruiting
6 participants
Started: Jul 22, 2019 · Completed: Apr 30, 2026
5 conditions3 sponsors1 location
NCT04021108
Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)
PHASE2Active, not recruiting
80 participants
Started: Jul 22, 2019 · Completed: Jun 30, 2026
1 condition2 sponsors5 locations
NCT03816111
Targeted Education ApproaCH to Improve Peritoneal Dialysis Outcomes Trial
NAActive, not recruiting
1,500 participants
Started: Jul 22, 2019 · Completed: Apr 30, 2025
4 conditions4 sponsors48 locations
NCT04020913
Skeletal Muscle Effects of GH in Boys
N/AActive, not recruiting
45 participants
Started: Jul 22, 2019 · Completed: Oct 30, 2025
2 conditions2 sponsors1 location
NCT03821792
Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer
PHASE2Active, not recruiting
60 participants
Started: Jul 22, 2019 · Completed: Oct 11, 2026
6 conditions2 sponsors1 location
NCT04245943
Rehabilitation - Physical Activity and Coping
NAActive, not recruiting
20 participants
Started: Jul 22, 2019 · Completed: Oct 31, 2024
1 condition1 sponsor1 location
NCT03962699
Impact of Weight Loss on the Human Sperm Epitranscriptome
N/AActive, not recruiting
45 participants
Started: Jul 20, 2019 · Completed: Dec 19, 2025
1 condition1 sponsor1 location
NCT03836040
Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine
PHASE3Active, not recruiting
457 participants
Started: Jul 19, 2019 · Completed: Oct 13, 2026
1 condition2 sponsors119 locations
NCT03789981
Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leukemia
N/AActive, not recruiting
75 participants
Started: Jul 19, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor14 locations
NCT04030338
Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer
N/AActive, not recruiting
58 participants
Started: Jul 19, 2019 · Completed: Jul 31, 2026
5 conditions2 sponsors7 locations
NCT03694262
The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib)
PHASE2Active, not recruiting
30 participants
Started: Jul 19, 2019 · Completed: Jan 5, 2026
2 conditions3 sponsors3 locations
NCT03999710
Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer
PHASE2Active, not recruiting
61 participants
Started: Jul 19, 2019 · Completed: Jul 31, 2026
5 conditions1 sponsor9 locations
NCT03981796
A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer
PHASE3Active, not recruiting
785 participants
Started: Jul 18, 2019 · Completed: Nov 26, 2026
1 condition3 sponsors169 locations
NCT03992755
Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil
PHASE3Active, not recruiting
92 participants
Started: Jul 18, 2019 · Completed: May 31, 2025
1 condition2 sponsors25 locations
NCT04057352
Citadel Embolization Device Study
NAActive, not recruiting
150 participants
Started: Jul 18, 2019 · Completed: Nov 15, 2026
1 condition1 sponsor26 locations
NCT04006457
Long-Term PF-06651600 for the Treatment of Alopecia Areata
PHASE3Active, not recruiting
1,052 participants
Started: Jul 18, 2019 · Completed: Jan 23, 2026
1 condition1 sponsor144 locations
NCT03672331
My Personalized Breast Screening
NAActive, not recruiting
53,142 participants
Started: Jul 18, 2019 · Completed: Dec 31, 2027
1 condition1 sponsor6 locations
NCT04050709
QUILT-3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid Cancers
PHASE1Active, not recruiting
16 participants
Started: Jul 18, 2019 · Completed: Nov 30, 2025
3 conditions1 sponsor1 location
NCT03979365
Envarsus XR Compared to Immediate Release Tacrolimus
PHASE4Active, not recruiting
240 participants
Started: Jul 18, 2019 · Completed: Jul 31, 2025
1 condition2 sponsors3 locations
NCT03791112
A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor
PHASE1Active, not recruiting
54 participants
Started: Jul 18, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04253483
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer
PHASE2Active, not recruiting
14 participants
Started: Jul 17, 2019 · Completed: Sep 1, 2027
5 conditions2 sponsors3 locations
NCT03726775
Trial Evaluating the Tolerance and Safety of Durvalumab - RT Combination for Treatment in SCCHN
PHASE2Active, not recruiting
61 participants
Started: Jul 17, 2019 · Completed: Aug 31, 2026
1 condition3 sponsors2 locations
NCT03443856
Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence
PHASE2Active, not recruiting
197 participants
Started: Jul 17, 2019 · Completed: Jun 30, 2026
1 condition1 sponsor28 locations
NCT03959293
Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma
PHASE2Active, not recruiting
107 participants
Started: Jul 17, 2019 · Completed: Nov 27, 2024
2 conditions2 sponsors35 locations
NCT03346135
Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma
PHASE2Active, not recruiting
31 participants
Started: Jul 17, 2019 · Completed: Nov 17, 2025
2 conditions2 sponsors2 locations
NCT03743649
Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care
PHASE2/PHASE3Active, not recruiting
110 participants
Started: Jul 17, 2019 · Completed: Dec 31, 2026
4 conditions2 sponsors3 locations
NCT04063709
Transcutaneous ARFI Ultrasound for Differentiating Carotid Plaque With High Stroke Risk
NAActive, not recruiting
80 participants
Started: Jul 17, 2019 · Completed: Nov 30, 2025
3 conditions2 sponsors1 location
NCT03970083
A Pilot Study of Quantitative Tumor Oxygen Measurements in Cervical Cancer
N/AActive, not recruiting
10 participants
Started: Jul 16, 2019 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT04151069
Re-Introducing Nuts in Allergic Patients
N/AActive, not recruiting
60 participants
Started: Jul 16, 2019 · Completed: May 30, 2024
1 condition2 sponsors1 location
NCT04179578
The Value of Lateral Release in Reconstruction of the Diaphragmatic Hiatus Hernia
NAActive, not recruiting
70 participants
Started: Jul 16, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05094466
Parent and Family Obesity Intervention in Reducing Obesity Risk in Racial Ethnic Minority Families
NAActive, not recruiting
120 participants
Started: Jul 16, 2019 · Completed: Feb 2, 2027
1 condition1 sponsor1 location